6 Form 4 filings for STOK between 2026-07-17 and 2026-08-18, from 5 filers. 6 discretionary (1 sales, 3 purchases). 4 of 6 state a filing-level total, summing to $855,242; the rest report only their largest transaction, so the true figure is higher.
| Filed | Filer | Role | Action | Shares largest txn | Price | Filing total | Txns |
|---|---|---|---|---|---|---|---|
| 2026-08-18 | Ticho Barry | CHIEF MEDICAL OFFICER | acquired | 10,000 | — | $152,690 | 3 |
| 2026-08-18 | Kaye Edward M. MD | acquired | 26,250 | — | $402,528 | 3 | |
| 2026-08-18 | Allan Jonathan | acquired | 6,000 | — | $91,639 | 3 | |
| 2026-08-05 | Ticho Barry | CHIEF MEDICAL OFFICER | sold | 5,907 | $28.95 | $208,385 | 2 |
| 2026-07-17 | Harrison Seth Loring (Director at Stoke Therapeutics, Inc.) filed a Form 4; no parseable transaction details were found in the filing. | ||||||
| 2026-07-17 | McCauley Thomas (Chief Scientific Officer at Stoke Therapeutics, Inc.) filed a Form 4; no parseable transaction details were found in the filing. | ||||||
| 6 filings · 5 filers · disclosed totals only | $855,242 (4/6) | — | |||||